Skip to content

Health Impact 360: Advancing Physical, Social, and Mental Health Toward Cardiovascular Disease Prevention in Community Settings

Health Impact 360: Advancing Physical, Social, and Mental Health Toward Cardiovascular Disease Prevention in Community Settings

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07034352
Acronym
HI360
Enrollment
328
Registered
2025-06-24
Start date
2025-06-20
Completion date
2026-12-01
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Health, Health Promotion

Keywords

Health Program, Health outcomes, Social health, Walking, Health Education and support, Mental health, social support, Health disparities, self management

Brief summary

The purpose of this clinical trial is to evaluate an evidence-based intervention, Health Impact 360, toward the promotion of cardiovascular health (CVH), including physical, mental, and social health outcomes, among adults living in marginalized communities. Study hypotheses include: * Participants in the Health Impact 360 intervention arm will have better CVH (i.e., a higher overall LE8 score) at the 16-week endpoint compared to the control. * Participants in the Health Impact 360 intervention arm will report better mental health (i.e., a lower perceived stress score) at the 16-week endpoint compared to the control. * Participants in the Health Impact 360 intervention arm will report better social support and well-being (i.e., higher emotional support and instrumental support scores and reduced social isolation) at the 16-week endpoint compared to control. * Participants with greater intervention engagement (e.g., better session attendance) will experience greater intervention impacts across all primary and secondary outcomes relative to the minimally engaged peers. Researchers will compare outcomes among intervention participants to outcomes among delayed intervention control participants who will be invited to participate in Health Impact 360 once all endpoint measures are collected. Participants will: * Engage in group-based programming twice per week for 8 weeks * Engage in group-based programming once per week for 8 weeks * Participate in survey-based and biometric data collection at two timepoints: baseline and 16-week endpoint * Self-monitor their physical activity via a study-provided pedometer

Interventions

BEHAVIORALHealth Impact 360

Participants will be assigned to a team and teams will meet 1-2 times per week for sessions at a local community organization. Sessions will be up to 2 hours long and will include two parts: (1) 30-60 minutes of activities related to physical, mental, social, financial, and community health, and (2) 60-75 minutes of group physical activity (walking), including stretches to warm up and cool down.

OTHERUsual care - Wait list control

Participants will be on this for approximately 16 weeks and be asked to complete data collection information at baseline and 16 weeks.

Sponsors

University of Michigan
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Detroit Hispanic Development Corporation
CollaboratorUNKNOWN
Eastside Community Network
CollaboratorUNKNOWN
Community Health and Social Service Center (CHASS)
CollaboratorUNKNOWN
Community Based Organization Partners
CollaboratorUNKNOWN
Michigan United
CollaboratorUNKNOWN
Hurley Medical Center
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Statisticians will be blinded to arm assignment during analysis.

Intervention model description

This is a waitlist-control trial. The intervention-randomized participants will receive the intervention first in "Wave 1" and the participants randomized to the control group, "Wave 2", will experience a delay in access to the program until after the end of the Wave 1 intervention period at each participating site.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* English or Spanish speaking * Able to participate in group-based programming

Exclusion criteria

\- All pregnant persons to prevent pregnancy-related biometric changes from biasing outcome analyses

Design outcomes

Primary

MeasureTime frameDescription
Change in Cardiovascular health (CVH) based on the Life's Essential 8 score (LE8)Baseline, 16 weeksLE8 CVH Score will be averaged for each participant at baseline and 16 weeks on the individual LE8 metrics (i.e., scores of 0-100 for eight items). An average score of 0 to 49 is defined as low CVH, 50 to 79 is moderate CVH, and 80 to 100 is high CVH.

Secondary

MeasureTime frameDescription
Change in mental health based on the perceived stress scaleBaseline, 16 weeksThe Perceived Stress Scale (PSS) is a 10-item scale that was developed to measure the degree to which situations in one's life are appraised as stressful. PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the four positively stated items (items 4, 5, 7, \& 8) and then summing across all scale items. Scores range from 0 to 40 with higher scores indicating a worse outcome.
Change in social health via the 4-item Patient-Reported Outcomes Measurement Information System (PROMIS) emotional support scaleBaseline, 16 weeksThis is a 4-item survey that participants select from never (1) - always (5). The score range is from 4-20 with a higher score indicating more emotional support.
Change in social health via the 4-item Patient-Reported Outcomes Measurement Information System (PROMIS) instrumental support scaleBaseline, 16 weeksThis is a 4-item survey that participants select from never (1) - always (5). The score range is from 4-20 with a higher score indicating more instrumental support.
Change in social health via the 4-item Patient-Reported Outcomes Measurement Information System (PROMIS) social isolation scaleBaseline, 16 weeksThis is a 4-item survey that participants select from never (1) - always (5). The score range is from 4-20 with a higher score indicating greater social isolation.

Countries

United States

Contacts

CONTACTMichelle Clayson
mclayson@umich.edu734-763-2003
PRINCIPAL_INVESTIGATORJennifer Garner, PhD, RD

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026